Mike Fucci joined Acadia Healthcare as an independent director in October 2020, bringing four decades of leadership experience from one of the world’s largest professional services firms. His appointment came shortly after his retirement as Chairman Emeritus of Deloitte U.S., where he had provided governance and operational leadership on matters including strategy, leadership succession, and risk mitigation.
Fucci served as Executive Chairman of Deloitte U.S. from 2015 to 2019, during which time the firm’s revenue grew 19 percent to $19 billion and headcount expanded 25 percent to over 100,000 employees. His tenure focused on redefining the board’s role as a governing body that upholds reputational excellence, cultivates leaders, and enhances succession processes.
Corporate Governance Leadership
While at Deloitte, Fucci established and co-chaired the Board Leadership Forum, a coalition of Fortune 500 board chairs and lead directors who convene to discuss research, trends, and perspectives relevant to the evolving business environment. This initiative reflected his commitment to advancing corporate governance practices across industries.
His extensive background in governance and strategic oversight made him an ideal addition to the behavioral health provider’s board. “His impressive tenure of leadership experience as a principal and practitioner at Deloitte U.S. makes him an ideal Board member for Acadia,” said Reeve B. Waud, Chairman of Acadia Healthcare’s board.
Timing and Industry Context
Mike Fucci’s appointment to the healthcare company came during a critical period of demand brought on by challenges associated with the COVID-19 pandemic. “I am honored to be joining the Acadia Board,” Fucci stated. “I look forward to supporting Acadia’s important role as a leading behavioral healthcare provider.”